HIV-positive TB patients on ART (antiretroviral therapy) in Sur
Sur: HIV-positive TB patients on ART (antiretroviral therapy) was 82.0% in 2024. ▲ Rising
Latest (2024)
82.0%
Change on year
down 10.9%
Rank
2nd
of 2 regions
All-time high
92.0%
in 2023
All-time low
10.0%
in 2005
Years of data
19
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Sur, 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in Sur stood at 82.0%.
Compared with earlier readings it is down 10.9% on the previous year and up 12.3% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Sur peaked at 92.0% in 2023 and was at its lowest, 10.0%, in 2005.
The long-run direction has been consistently rising across the 19 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Sur, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 18.0% | — |
| 2005 | 10.0% | -44.4% |
| 2008 | 32.0% | +220.0% |
| 2009 | 50.0% | +56.2% |
| 2010 | 38.0% | -24.0% |
| 2011 | 55.0% | +44.7% |
| 2012 | 78.0% | +41.8% |
| 2013 | 58.0% | -25.6% |
| 2014 | 73.0% | +25.9% |
| 2015 | 62.0% | -15.1% |
| 2016 | 56.0% | -9.7% |
| 2017 | 70.0% | +25.0% |
| 2018 | 84.0% | +20.0% |
| 2019 | 89.0% | +6.0% |
| 2020 | 77.0% | -13.5% |
| 2021 | 75.0% | -2.6% |
| 2022 | 53.0% | -29.3% |
| 2023 | 92.0% | +73.6% |
| 2024 | 82.0% | -10.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 27.5% | 10.0% | 50.0% | 4 |
| 2010s | 66.3% | 38.0% | 89.0% | 10 |
| 2020s | 75.8% | 53.0% | 92.0% | 5 |
Countries ranked near Sur
- 1 Seychelles 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Hong Kong, China 100.0% compare
- 1 Ecuador 100.0% compare
- 1 Burkina Faso 100.0% compare
- 1 Oman 100.0% compare
- 1 Togo 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Serbia 100.0% compare
- 1 Israel 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Estonia 100.0% compare
- 1 Brunei Darussalam 100.0% compare
- 1 Slovakia 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Grenada 100.0% compare
- 1 Armenia 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Bulgaria 100.0% compare
- 1 Georgia 100.0% compare
- 1 Sierra Leone 100.0% compare
- 1 Bahrain 100.0% compare
- 1 Azerbaijan 100.0% compare
- 1 Egypt 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Guinea 100.0% compare
- 1 Tajikistan 100.0% compare
- 1 North Macedonia 100.0% compare
- 1 Saint Lucia 100.0% compare
- 1 Cuba 100.0% compare
- 1 Macau, China 100.0% compare
- 1 Albania 100.0% compare
- 1 Nicaragua 100.0% compare
- 1 Malta 100.0% compare
- 1 Jordan 100.0% compare
- 1 Mongolia 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Chad 100.0% compare
- 1 Qatar 100.0% compare
- 1 Malawi 100.0% compare
- 1 Iraq 100.0% compare
- 1 Tunisia 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Lebanon 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Saudi Arabia 100.0% compare
- 1 Panama 100.0% compare
- 1 Comoros 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Dominica 100.0% compare
- 1 Barbados 100.0% compare
- 1 United Arab Emirates 100.0% compare
- 1 Syrian Arab Republic 100.0% compare
More health data for Sur
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Measles - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, gaps filled 8 (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Total tetanus - number of reported cases, gaps filled 0 (2025)
- Number of neonatal deaths, annual growth rate -3.67 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -100 % change on previous year (1991)
- Pertussis - number of reported cases, annual growth rate -100 % change on previous year (2023)
- Total tetanus - number of reported cases, annual growth rate -100 % change on previous year (2021)
- Measles - number of reported cases 0 (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Sur?
- Hiv-positive tb patients on art (antiretroviral therapy) in Sur was 82.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Sur?
- The highest recorded value was 92.0% in 2023.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Sur?
- The lowest recorded value was 10.0% in 2005.
- How does Sur rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd out of 2 regions with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Sur?
- Over the last ten years it is up 12.3%. The long-run trend across the full record is rising.
- Where does this Sur data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).